Jacqueline C Tanaka Selected Research

Achromatopsia 2

1/2019	High-Throughput Ca2+ Flux Assay To Monitor Cyclic Nucleotide-Gated Channel Activity and Characterize Achromatopsia Mutant Channel Function.
7/2005	Transmembrane S1 mutations in CNGA3 from achromatopsia 2 patients cause loss of function and impaired cellular trafficking of the cone CNG channel.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jacqueline C Tanaka Research Topics

Disease

3	Color Vision Defects (Color Blindness) 01/2019 - 07/2010
2	Achromatopsia 2 01/2019 - 07/2005
2	Blindness (Hysterical Blindness) 01/2019 - 01/2014
2	Channelopathies 07/2010 - 07/2005
1	Photophobia (Light Sensitivity) 01/2015

Drug/Important Bio-Agent (IBA)

3	Retinaldehyde (Retinal)IBA 01/2019 - 07/2005
2	Cyclic Nucleotide-Gated Cation ChannelsIBA 01/2019 - 01/2014
1	Aspartic Acid (Aspartate)FDA Link 01/2014
1	AsparagineIBA 01/2014
1	AcidsIBA 01/2014
1	Cone OpsinsIBA 07/2010
1	Cyclic NucleotidesIBA 07/2005
1	Glycerol (Glycerine)FDA LinkGeneric 07/2005

Therapy/Procedure

1	Therapeutics 07/2010